Summary: Toni Choueiri, MD, kidney cancer specialist at Dana-Farber Cancer Institute, discusses surgical considerations and multidisciplinary care for localized kidney cancer, adjuvant therapies largely falling short of expectations, and the plethora of frontline therapies available in metastatic disease.
